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Retroviruses are positive-sense, single-stranded RNA viruses that reverse transcribe their
RNA genomes into double-stranded DNA for integration into the host cell chromosome.
The integrated provirus is used as a template for the transcription of viral RNA. The
full-length viral RNA can be used for the translation of the Gag and Gag-Pol structural
proteins or as the genomic RNA (gRNA) for encapsidation into new virions by the Gag
protein. The mechanism by which Gag selectively incorporates unspliced gRNA into
virus particles is poorly understood. Although Gag was previously thought to localize
exclusively to the cytoplasm and plasma membrane where particles are released, we
found that the Gag protein of Rous sarcoma virus, an alpharetrovirus, undergoes transient
nuclear trafficking. When the nuclear export signal of RSV Gag is mutated (Gag.L219A),
the protein accumulates in discrete subnuclear foci reminiscent of nuclear bodies such
as splicing speckles, paraspeckles, and PML bodies. In this report, we observed that
RSV Gag.L219A foci appeared to be tethered in the nucleus, partially co-localizing with
the splicing speckle components SC35 and SF2. Overexpression of SC35 increased
the number of Gag.L219A nucleoplasmic foci, suggesting that SC35 may facilitate the
formation of Gag foci. We previously reported that RSV Gag nuclear trafficking is required
for efficient gRNA packaging. Together with the data presented herein, our findings
raise the intriguing hypothesis that RSV Gag may co-opt splicing factors to localize
near transcription sites. Because splicing occurs co-transcriptionally, we speculate that
this mechanism could allow Gag to associate with unspliced viral RNA shortly after its
transcription initiation in the nucleus, before the viral RNA can be spliced or exported
from the nucleus as an mRNA template.
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Introduction
Retroviruses are significant human and animal pathogens, causing cancer and immunodeficiency
syndromes in a wide variety of species. Most well-known is the human immunodeficiency
virus type 1 (HIV-1), the etiological agent of acquired immunodeficiency syndrome
(AIDS). Many retroviruses that infect animals have served as important model systems for
unraveling the mechanisms of retroviral replication, pathogenesis, and host defense. The first
retrovirus discovered, the avian alpharetrovirus Rous sarcoma virus (RSV), has proven to be
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among the most valuable, launching challenges to existing
dogmas that led to the discovery of reverse transcription and
cellular oncogenes (reviewed in Parent, 2012).
Retroviruses are enveloped, positive-sense, single-stranded
RNA viruses that package two copies of their genomes
into virions. Following viral entry, the retroviral genomic
RNA (gRNA) undergoes reverse transcription to generate a
complementary, double-stranded DNA that integrates into the
host cell genome to form the provirus. The integrated provirus is
used as a template for the cellular RNA polymerase II to direct
the synthesis of retroviral RNA. The genome-length retroviral
transcript may be spliced to create subgenomic mRNAs, which
are exported from the nucleus to synthesize other viral proteins.
Alternatively, the full-length RNA may remain unspliced with
two potential outcomes: it may serve as the mRNA template
for the translation of the Gag and Gag-Pol structural proteins
or it may be bound by the Gag protein for packaging into new
virions as the gRNA. The Gag protein selects the gRNA for
encapsidation through a high-affinity interaction between the
nucleocapsid (NC) domain of Gag and the psi (9) packaging
sequence in the 5′ untranslated region of the viral RNA (Shank
and Linial, 1980; Aronoff and Linial, 1991; Aronoff et al., 1993;
Berkowitz et al., 1995, 1996; Butsch and Boris-Lawrie, 2002; Lee
et al., 2003; Lee and Linial, 2004; Zhou et al., 2005, 2007).
Historically, it was thought that the initial Gag-gRNA
interaction occurred in the cytoplasm or at the plasma
membrane, where budding virions are released. Mounting
evidence, including recent studies using sensitive microscopic
imaging techniques, indicates that the Gag proteins of several
retroviruses includingHIV-1, RSV,mousemammary tumor virus
(MMTV), feline immunodeficiency virus (FIV), prototype foamy
virus (PFV), Mason-Pfizer monkey virus (MPMV), and murine
leukemia virus (MLV) undergo nuclear localization (Nash et al.,
1993; Schliephake and Rethwilm, 1994; Amendt et al., 1995; Risco
et al., 1995; Scheifele et al., 2002; Tobaly-Tapiero et al., 2008;
Prizan-Ravid et al., 2010; Müllers et al., 2011; Renault et al., 2011;
Elis et al., 2012; Kemler et al., 2012; Beyer et al., 2013; Lochmann
et al., 2013). In the case of RSV, a connection has been established
between Gag nuclear trafficking and gRNA incorporation.
Genetic experiments demonstrated that targeting an RSV Gag
mutant strongly to the plasma membrane reduced its nuclear
trafficking, leading to the production of virus particles that
encapsidate significantly reduced levels of gRNA (Scheifele et al.,
2002). However, inserting an exogenous nuclear localization
signal (NLS) into this Gag mutant restores gRNA packaging to
nearly normal levels (Garbitt-Hirst et al., 2009). These results
raise the intriguing possibility that nucleocytoplasmic transport
of RSV Gag is required for proficient packaging of gRNA.
Treatment of RSV Gag expressing cells with the CRM1
inhibitor leptomycin B (LMB) traps Gag in the nucleus, and
genetic mapping studies revealed a nuclear export signal (NES) in
the p10 domain (Figure 1A). Mutation of hydrophobic residues
within the NES causes Gag to accumulate in numerous, discrete
nucleoplasmic foci and within nucleoli (Scheifele et al., 2002,
2005; Kenney et al., 2008; Lochmann et al., 2013). These
nucleoplasmic foci are also observed at a lower frequency in
the nuclei of cells expressing the wild-type Gag protein in the
FIGURE 1 | Characterization of Gag.L219A nuclear foci. (A) Schematics
of the CFP-tagged wild-type RSV Gag protein (top) and the Gag.L219A
nuclear export mutant (bottom), with leucine 219 in the p10 domain mutated
to alanine. (B) Confocal micrographs of fluorescent protein-tagged wild-type
Gag (left panel) and Gag.L219A (right panel) in QT6 cells. On the right hand
image, the entire cell is outlined with a thin green line. (C) QT6 cells expressing
Gag.L219A-CFP were imaged using time-lapse 3D confocal microscopy. A
series of single optical slices through the nucleus were captured every 8 s for
(Continued)
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FIGURE 1 | Continued
10min. After acquisition, the images were reconstructed as a 3D time-course
using Imaris imaging software, and a single representative nucleus is shown
with time = 0 on the left and t = 10min on the right. The nucleus of each cell is
outlined by a white dashed line. In the top panels, Gag foci (green) are shown.
In the middle panels, the particle tracks were superimposed on the Gag foci,
with white squares placed at the center of each focus (left) and tracks colored
from blue (time = 0) to red (t = 10min) in the middle panels. The particle tracks
alone are shown in the bottom panel. In the lower left corner of the right
image, a higher magnification of the particle tracks shows the course of the
particles over the entire time period. (D) A histogram representing the
anomalous diffusion coefficient α values for 149 nuclear foci is provided.
absence of LMB treatment (Figure 1B), providing evidence that
formation of nuclear foci cannot be completely attributed to
drug treatment or mutation. Furthermore, we demonstrated that
Gag NES mutant proteins remain assembly-competent, as they
interact with wild-type Gag proteins and can be rescued into
virus particles (Kenney et al., 2008). The number and size of Gag
nuclear foci increase with higher protein expression levels of the
NESmutant Gag protein (data not shown), therefore it is possible
that smaller accumulations of wild-type Gag proteins may form
at lower expression levels, but these small foci are not readily
detected by imaging studies.
To characterize the intranuclear population of RSV Gag
proteins, we undertook the present studies to determine
whether Gag nuclear foci share properties with host proteins
that accumulate in nuclear bodies. These well-characterized
subnuclear bodies are dynamic, non-membrane bound structures
where nuclear proteins that perform specific functions are
concentrated (Dundr and Misteli, 2010; Mao et al., 2011),
including nuclear speckles, paraspeckles, and promyelocytic
leukemia (PML) bodies. Nuclear speckles store and modify
splicing factors that process pre-mRNAs (Mintz and Spector,
2000; Spector and Lamond, 2011). Paraspeckles are nucleated
by the binding of the PSP1 protein to the long noncoding
RNA NEAT1 and function in the retention of incompletely or
aberrantly processed mRNAs (Fox et al., 2002; Prasanth et al.,
2005; Bond and Fox, 2009; Clemson et al., 2009; Fox and
Lamond, 2010; Souquere et al., 2010; Naganuma and Hirose,
2013; Yamazaki and Hirose, 2015). PML bodies form in response
to DNA damage, stress, and viral infection (Dundr and Misteli,
2010; Mao et al., 2011). In this report, we examined whether
the nuclear foci formed by nuclear-restricted Gag proteins have
features in common with nuclear bodies and whether Gag
localizes to any of the same nucleoplasmic sites as components
of host nuclear bodies.
Materials and Methods
Expression Vectors
RSV Gag expression plasmids: pGag-GFP (Scheifele et al., 2002),
pGag.L219A-CFP, pGag.L219A-YFP were described previously
(Kenney et al., 2008). Expression plasmids used to encode human
nuclear body proteins PSF and p54/nrb were constructed using
PCR to exchange YFP for GFP from plasmids pGFP-PSF and
pGFP-p54nrb, which were gifts from Dr. James Patton (Dye and
Patton, 2001; Peng et al., 2002); human pSC35-YFP and human
pYFP-SF2/ASF were gifts fromDr. David Spector (Prasanth et al.,
2003); human pYFP-SUMO1 and human pCFP-PML were gifts
from Dr. Mary Dasso (Ayaydin and Dasso, 2004); human pYFP-
PSP1 was a gift from Dr. Angus Lamond, University of Dundee,
UK; and murine pGFP-Clk1 was a gift from Alan Cochrane
(Wong et al., 2011) (with permission from John Bell, University
of Ottawa), in which GFP was exchanged with mCherry using
PCR amplification and restriction fragment exchange.
Cells, Transfections, Fixation, and
Immunofluorescence
QT6 cells, chemically transformed quail fibroblasts (Moscovici
et al., 1977), were maintained as described (Craven et al., 1995),
seeded at 0.2×106 on coverslips in 35mmdishes containing glass
coverslips and transfected using the calcium phosphate method
(Fujiwara et al., 1988) with the following plasmids: pGag.L219A-
CFP (1.5µg), pGag-CFP (500 ng), pCMV.SC35-YFP (100 and
125 ng), pCMV.YFP-SF2 (125 ng), pYFP-PSP1 (100 and 125 ng),
pYFP-Nrb (100 ng), and pYFP-PSF (100 ng). Cells were fixed 16 h
post-transfection in 3.7% PFA in PHEM buffer (120mM PIPES,
55mM HEPES, 20mM EGTA, and 16.5mM MgSO4, pH to 7.0)
(Matic et al., 2008) for 10min, incubated with DAPI at 5µg/ml
for 1min and mounted on slides in SlowFade Antifade mounting
medium (Invitrogen).
HeLa cells (Azad et al., 1993) were maintained as described
(Lochmann et al., 2013), seeded at 0.4–0.5× 106 on coverslips in
35mm dishes containing glass coverslips, and transfected using
Lipofectamine 2000 (Invitrogen) with the following plasmids:
pGag.L219A-CFP (4µg), pCMV.SC35-YFP (1µg), pCMV.YFP-
SF2 (500 ng), pYFP-PSP1 (250 ng), pYFP-nrb (250 ng), and
pYFP-PSF (250 ng). Cells were fixed between 18 and 23 h post-
transfection with 3.7% PFA in PHEM for 10min at room
temperature, stained with DAPI at 5µg/ml for 1min, and
mounted on slides in SlowFade Antifade mounting medium
(Invitrogen). To detect endogenous phosphorylated RS domain
proteins, cells were fixed in 3.7% PFA in PHEM for 10min,
permeabilized with 0.25% Triton X-100 for 10min at room
temperature, blocked with 10% BSA in PBS for 1 h, incubated for
1 h with mouse anti-SC35 (Sigma S4045) antibody at a dilution
of 1:1000, which recognizes the phosphorylated RS domains of
the splicing factors SC35 and SF2, in 3% BSA/0.01% Tween-
20 in PBS, and incubated with donkey anti-mouse Alexa 647
(Invitrogen) at a 1:1000 dilution for 1 h at room temperature.
Laser-scanning Confocal Microscopic Imaging
Cells were imaged using a Leica SP8 TCS scanning confocal
microscope equipped with a White Light Laser (WLL) and argon
laser using a 63X oil immersion objective. Sequential scanning
between frames was used to average four frames for each image.
DAPI was excited with the 405 nm UV laser at 10% laser power
and emission detection between 415 and 450 nm using a PMT
detector. CFP was imaged using theWLL excited with the 470 nm
laser line and a hybrid detector window of 475–500 nm. YFP was
imaged using the WLL with a laser line excitation of 514 nm
and a hybrid detector window of 518–650 nm. Alexa 647 was
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imaged using the WLL with the 647 laser line and the hybrid
detector window ranged from 652 to 775 nm. mCherry was
imaged using the 587 nm laser line and the hybrid detector
window of 592–637 nm. All channels using the hybrid detectors
had a time gating of 0.3 to 6.5 ns.
Particle Tracking in Living Cells
QT6 cells seeded at a density of 0.2 × 106 were cultured
in 35-mm glass-bottomed dishes (MatTekCorporation) and
transfected with 1.5µg pGag.L219A-CFP. Cells were imaged
on a live cell stage equilibrated to 38.5◦C with 5% CO2 at
16 h post-transfection using a Leica SP8 TCS scanning confocal
microscope to capture 3D time-lapse images with a 63X water
objective. Imaging was performed with a line average of two
using the WLL with a laser line excitation of 470 nm and a
hybrid detector window of 475–601 nm. A series of 0.3µm
ocular slices were captured to create a z-stack encompassing the
entire nucleus approximately every 8 s for 10min at 1400Hz.
The captured data was imported into Imaris analysis software
(v8.0 Bitplane) to create a 3D volume rendering. Using the
Imaris spot tool, Gag.L219A-CFP foci that measured ≤650 nm
in diameter were identified in 3D space and tracked using
Brownian motion detection. Correction for 3D drift was applied
within the software, and only foci that were identified during the
entire 10min time-lapse period were analyzed. After focal drift
compensation was performed, a line representing the movement
of each individual particle was then superimposed onto the
3D time-lapse images. The Imaris software reported statistics
for individual and average particle movement, and the x, y, z
positions for each individual particle at each time point was
exported from Imaris into MatLab using a script publically
available at https://bitbucket.org/tim_lochmann/imaris-parser-
for-msdanalyzer. The mean squared displacements (MSD) over
time and diffusion coefficients were analyzed using the MSD
analyzer script package (Tarantino et al., 2014). The MSD over
time for each focus was calculated, and curves were fitted to
the data. The α (anomalous diffusion coefficient) was calculated
for 149 foci that had a curve fit of R2 > 0.8. The binned α
values were displayed as a histogram. The value for α was used to
determine the type of mobility of each particle as defined by these
parameters: α< 0.1, confined diffusion; 0.1≤ α< 0.9, obstructed
diffusion; 0.9 ≤ α < 1.1, simple diffusion; and α ≥ 1.1, directed
motion (Bacher et al., 2004).
Quantitative Image Analyses
To quantitatively analyze co-localization of fluorescent
proteins in cells, ImageJ (v1.49p, Schindelin et al., 2012)
was used to calculate Mander’s statistics using the Just Another
Colocalization Plugin (JACoP) (Bolte and Cordelières, 2006).
A minimum of 8 QT6 cells and 4 HeLa cells were analyzed per
condition, the mean ± standard error of the mean for each
Mander’s score was calculated, and the values were analyzed
statistically using a two-tailed, unpaired t-test. Outliers were
determined and removed using the Grubbs test using α = 0.05.
(http://graphpad.com/quickcalcs/Grubbs1.cfm). Anti-Phospho
RS domain staining was quantitatively analyzed using ImageJ
by measuring the mean signal intensity of the nucleus for
the antibody channel in cells with or without Gag.L219A and
statistical analysis was performed as described above.
For quantification of nuclear foci, QT6 cells were seeded
on coverslips at 0.4 × 106 and transfected with 1.5µg of
pGag.L219A-CFP and 125 ng of plasmids expressing YFP-tagged
SF2, SC35, or PSP1 using the calcium phosphate method.
DF1 cells (Himly et al., 1998) were seeded on coverslips
at a density of 0.6 × 106, and co-transfected with 4µg of
pGag.L219A-CFP and 1µg of each plasmid expressing a YFP-
tagged host nuclear factor (SC35, SF2, or PSP1) using FuGene
HD (Promega). Sixteen hours post-transfection, cells were fixed
with 3.7% paraformaldehyde in PHEM buffer for 10min at room
temperature and mounted on slides with SlowFade Antifade
mounting medium. Images were captured with a Deltavision DV
Elite microscope (Applied Precision) using a 60 × (DF1 cells)
or 100 × (QT6 cells) oil immersion objective with N = 1.514
oil using a CoolSNAPHQ2 (Photometrics) camera. Images were
deconvolved and composite channel images were exported as
RGB TIFF files post-acquisition using softWorx (v5.5.1, Applied
Precision). ImageJ (v1.49o) (Schneider et al., 2012) was used
for downstream export and analysis. A macro (modified from
Alex Herbert, “ImageJ Batch Processing.” http://www.sussex.
ac.uk/gdsc/intranet/pdfs/ImageJBatchProcessing.pdf) was used
to split, recolor, and save the composite channel image into
the constituent CFP and YFP channel images. The section
through the widest diameter of the nucleus was cropped from
a single optical slice obtained from a minimum of 20 DF-1
cells and 16 QT6 cells. The number of Gag.L219A-CFP nuclear
foci were counted using the same modified macro, which first
automatically adjusted the histogram of each image from 1 to the
maximum pixel intensity value of that image, and then applied
a pixel intensity threshold determined empirically for each slide.
Foci were identified with a size constraint of ≥4 pixels squared
and with no circularity constraint. Outliers were removed, as
determined by the Grubbs test using α = 0.05. Prism statistical
package (GraphPad Software 5.04) was used to create scatter
plots showing the mean and standard error of the mean for the
number of Gag nuclear foci, and a two-tailed, unpaired t-test was
performed.
Results
RSV Gag.L219A Nuclear Foci Exhibit Obstructed
Diffusion
The fluorescently-tagged wild-type RSV Gag protein (Gag-
GFP) localizes primarily to the plasma membrane with the
visualization of several small foci in the nucleus when examined
using confocal microscopy (Figures 1A,B, top left panel). By
contrast, the Gag L219A mutant (Gag.L219A-CFP), which
contains a single amino acid change that inactivates the NES in
the p10 domain, is predominantly localized to the nucleus within
numerous, discrete, punctate foci (Figures 1A,B, top right panel)
(Scheifele et al., 2005). As previously described, Gag.L219A also
concentrates in the nucleolus in a subset of cells and undergoes
rapid exchange with Gag proteins in the nucleus (Lochmann
et al., 2013). However, we had not reported the characteristics of
Gag proteins localized to nucleoplasmic puncta. To examine the
kinetic properties of Gag.L219A localized within nucleoplasmic
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foci, we used live-cell confocal imaging to examine themovement
of the foci over a 10min time period with z-stacks acquired
every 8 s (Figure 1C). Following acquisition, the x, y, and z
coordinates of each of 149 foci that were tracked during the
entire 10min imaging period were analyzed to measure particle
movement. The mean square displacement (MSD) over time of
each particle track was analyzed and a curve was fitted to the
data (Tarantino et al., 2014). Using stringent parameters for curve
fitting (R2 > 0.8) of each particle track, the data from 149 Gag
nuclear foci were further analyzed for their distance of diffusion.
The average anomalous diffusion coefficient (α) of these tracked
particles was found to be 0.46 ± 0.16 with high significance
for α values < 1.0 (p = 1.4 × 10−82), indicating a pattern of
obstructed diffusion based on definitions previously described by
Bacher and colleagues (confined diffusion, α < 0.1; obstructed
diffusion, 0.1 ≤ α < 0.9; simple diffusion, 0.9 ≤ α < 1.1;
directed motion, α ≥ 1.1) (Bacher et al., 2004). The α values were
binned to plot a histogram (Figure 1D), which indicated that
100% of nuclear Gag foci display obstructed diffusion, indicating
that the movement of each Gag focus has a limited range of
movement, suggesting that Gag molecules may be tethered to a
cellular partner within the nucleus.
Analysis of Gag.L219A Co-localization with Host
Proteins in Subnuclear Bodies
The particle tracking data suggest that Gag.L219A foci appeared
to be tethered in foci which resemble subnuclear bodies. To
determine whether Gag.L219A co-localized with host proteins
in subnuclear bodies, we expressed fluorescently-tagged splicing
factors that are components of speckles (SC35 and SF2);
paraspeckles (PSP1, PSF, and p54nrb); or PML bodies (PML and
SUMO1). Plasmids expressing these nuclear body components
tagged with YFP were used to co-transfect avian (QT6) and
human (HeLa) cells with pGag.L219A-CFP. We expected human
SC35 and SF2 to form characteristic splicing speckles in QT6 cells
due to the high level of conservation between human and chicken
orthologs (98.19 and 98.79% amino acid identity, respectively).
However, SC35 and SF2 appeared more diffuse in QT6 cells even
when a low amount of plasmid DNA was used for transfection
(100 ng), although there were areas of consolidation where the
protein was concentrated (Figure 2A). Of interest, both SC35
and SF2 co-localized with Gag.L219A foci to a high degree.
Quantitative Mander’s analysis performed in 8 cells revealed that
a mean of 69.8± 4.7% of Gag.L219A co-localized with SC35 and
61.5 ± 5.2% of Gag.L219A with SF2 (Figure 2C). To determine
whether co-localization was present in 3-dimensions, z-stacks
were obtained and reconstructions were performed using Imaris
imaging analysis software (Supplemental Movie S2). Rendering
of the Gag.L219A (red) and SC35 (green; Figure 2D, left) or
SF2 (Figure 2D, right) signals revealed that Gag.L219A/SC35 and
Gag.L219A/SF2 co-localized in the x, y, and z dimensions and
appear to be in close proximity, at least based on the limits
of resolution of the microscopic images obtained (theoretical
resolution 250 nm in the x and y planes and 600 nm in
the z plane). For Gag.L219A/SC35 and Gag.L219A/SF2, the
Mander’s co-localization values were statistically significantly
higher (p < 0.0001 in both cases) than the quantitative
co-localization measured between Gag.L219A and proteins that
reside in paraspeckles (p54nrb, PSF, and PSP1) or PML bodies
(PML and SUMO1) (Figures 2B,C). Together, these data suggest
that Gag.L219A protein accumulated at subnuclear locations
enriched in splicing speckle components SC35 and SF2.
Next, because we observed co-localization between
Gag.L219A and human SC35 and SF2 expressed in avian
cells, we wanted to determine whether similar co-localization
patterns would be observed in human cells, in which the
localization of splicing factors has been more extensively studied.
When expressed alone, SC35 adopted its characteristic speckled
appearance; however, co-expression with Gag.L219A resulted
in a more diffuse pattern, and there was a high degree of
co-localization between the proteins (79.7 ± 2.5% of Gag co-
localized with SC35; Figures 3A,B). SF2 accumulated in speckles
when expressed alone, and SF2 also showed a high degree of
co-localization with Gag.L219A (60.6± 6%). Gag co-localization
was significantly higher with SC35 compared to SF2 (p = 0.0192)
and both SC35 and SF2 were more strongly associated with
Gag.L219A compared to p54nrb, PSF or PSP1 (p < 0.0001).
Analysis of cells co-expressing Gag.L219A and PML or SUMO1
could not be performed due to cell toxicity (data not shown).
To determine whether Gag.L219A foci co-localized
with endogenous nuclear splicing speckles, we performed
immunofluorescence using an antibody that recognizes the
phosphorylated RS domains of SF2 and SC35 (Figure 4A).
Gag.L219A accumulated in nuclear foci in transfected HeLa cells
that appeared similar to those observed in QT6 cells (Figure 4B).
In cells expressing Gag.L219A, overlapping signals were observed
at the intersection of the phosphorylated SR domain proteins
and Gag.L219A foci, which appeared to be juxtaposed (see
enlarged image in bottom row of Figure 4C), suggesting that Gag
foci form near accumulations of splicing speckle components.
Of note, in HeLa cells expressing Gag.L219A, the amount of
endogenous SC35/SF2 staining was dramatically reduced, as
indicated by the statistically significant (p < 0.001) decrease
in the mean signal intensity of the anti-phospho RS antibody
channel (Figure 4C, solid arrowhead) compared to cells in which
there was no Gag expression (open arrowhead). This result
suggests that expression of Gag.L219A interferes with staining of
endogenous phospho RS domains of splicing factors, although
the mechanism remains unclear.
Co-expression of Clk1 Enhances Co-localization
of Gag.L219A with SC35 and SF2
Phosphorylation is a major mechanism for regulating the
localization of SR proteins in the nucleus (Yeakley et al., 1999),
therefore we examined whether the degree of phosphorylation of
splicing factors SC35 and SF2 influenced their association with
Gag.L219A. To that end, murine Clk1, an SR protein kinase
(SRPK) that phosphorylates the RS domains of SC35 and SF2
(Gui et al., 1994; Colwill et al., 1996; Nayler et al., 1997; Koizumi
et al., 1999; Aubol et al., 2002; Ngo et al., 2005) was expressed as
an mCherry fusion protein in QT6 cells, either alone (Figure 5A)
or in conjunction with Gag.L219A-CFP, SC35-YFP or YFP-SF2
(Figure 5B). When co-expressed with Gag.L219A, there was no
significant co-localization with Clk1-mCherry (Figure 5B, upper
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FIGURE 2 | Localization of Gag.L219A with host nuclear body proteins in QT6 cells. (A) Localization of Gag.L219A and nuclear body proteins in
singly transfected QT6 cells. (B) Co-localization analysis between Gag.L219A and the indicated nuclear body proteins in co-transfected QT6 cells. Merging
of Gag.L219A and nuclear body marker protein channels is displayed (Overlay). The DAPI channel is also depicted. The percentage of Gag.L219A with
each factor is depicted in the Gag.L219A channel with the standard error of the mean. (C) Scatterplot depicting the mean and standard error of the mean
of Gag.L219A co-localization with each of the nuclear body protein. (D) Still image from Supplemental Video 1 that closely examines a surface rendering of
SC35 (green) and Gag.L219A (red). (E) Still image from Supplemental Video 2 that closely examines a surface rendering of SF2 (green) and Gag.L219A
(red).
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FIGURE 3 | Localization of Gag.L219A with host nuclear body proteins in HeLa cells. (A) Localization of Gag.L219A and nuclear body proteins in singly
transfected HeLa cells (B) Co-localization analysis between Gag.L219A and the indicated nuclear body proteins in co-transfected HeLa cells. Merging of Gag.L219A
and nuclear body marker protein channels is displayed (Overlay). The DAPI channel is also depicted. The percentage of Gag.L219A with each factor is depicted in the
Gag.L219A channel with the standard error of the mean. (C) Scatterplot depicting the mean and standard error of the mean of Gag.L219A co-localization with each of
the nuclear body proteins.
row). However, as expected, there was co-localization between
Clk1/SC35 and Clk1/SF2 (Figure 5B, lower rows) because Clk1
phosphorylates both SC35 and SF2.
In cells expressing Gag.L219A/Clk1/SC35 (Figure 5C, upper
row), the degree of Gag co-localization with SC35 increased
to 73.5% ± 5% (compared to 69.8% without Clk1, Figure 2),
although the increase was not statistically significant. However,
Clk1 co-expression did significantly increase the co-localization
of Gag.L219A with SF2 to 84% ± 2.2% (compared to 62.9%
without Clk1, Figure 2; p = 0.0066). To assess whether Clk1
hyperphosphorylated YFP-SF2 and SC35-YFP in QT6 cells, we
performed Western blotting of nuclear lysates (Supplemental
Figure 1). For both SF2 and SC35, there was a change in the
migration of the hyperphosphorylated proteins (red asterisks)
in cells co-expressing Clk1-mCherry compared to the position
of YFP-SF2 and SC35-YFP isolated from cells not expressing
Clk1-mCherry (red circles). Treatment of the nuclear lysates
with calf intestinal phosphatase dephosphorylated the proteins,
as demonstrated by the faster migration of phosphatase-treated
forms of SF2 and SC35, consistent with previous reports
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FIGURE 4 | Gag.L219A localization with endogenous splicing speckles in HeLa cells. (A) Visualization of endogenous splicing speckles in HeLa cells using
immunofluorescence with α-phospho RS antibody (also called α-SC35 antibody; see Materials and Methods). (B) Localization of Gag.L219A in unstained HeLa cells
fixed and permeabilized using the conditions outlined in Materials and Methods used to visualize endogenous splicing speckles. (C) Gag.L219A transfected HeLa
cells were stained with α-phospho RS antibody. The Gag.L219A and α-phospho RS channels were combined (Overlay). This merged image was overlaid with the
DAPI channel (Overlay with DAPI). The same region from each channel denoted by the white box was cropped, enlarged, and displayed in the bottom panel. The
intensity of α-phospho RS antibody decreased in the presence of Gag.L219A (indicated by solid arrowhead) compared to cells in which Gag.L219A was not
expressed (indicated by open arrowhead) (p < 0.001; 6 cells were analyzed per condition).
(Ngo et al., 2005). Together, these results suggest that the
association of Gag.L219A with splicing factors, particularly SF2,
was enhanced by hyperphosphorylation of the RS domain.
The Number of Nuclear Gag.L219A Foci
Increases with SC35 Overexpression
During the course of our imaging studies, we noticed that the
number of nuclear Gag.L219A-CFP foci appeared to increase
in cells that co-expressed SC35-YFP. To determine whether
this effect was specific for SC35, we compared the number
of nuclear Gag.L219A foci in cells expressing Gag.L219A-CFP
alone compared to cells transfected with equal amounts of
pSC35-YFP, pYFP-SF2, or pYFP-PSP1 (Figure 6A). In cells
expressing Gag.L219A alone, the average number of Gag foci
was approximately 22 per nucleus, whereas upon co-expression
of SC35-YFP, the average number of Gag nucleoplasmic foci
increased significantly to 36 (Figure 6B, p = 0.0003). By
contrast, co-transfection of equal amounts of pGag.L219A with
pYFP-SF2 or pYFP-PSP1 did not lead to a significant change in
the number of nuclear Gag foci. This experiment was repeated in
DF1 cells with the same outcome, indicating that the result was
not specific to QT6 cells (data not shown).
Discussion
The biological role of retroviral Gag proteins in the nucleus is
not well understood, even though several Gag proteins have been
observed within the nucleus (Parent, 2011; Stake et al., 2013).
RSV is unique among retroviral Gag proteins because the protein
accumulates in the nucleus when nuclear export is blocked by
treatment of cells with LMB and a CRM1-mediated nuclear
export signal (NES) was identified in the p10 region of Gag
(Scheifele et al., 2002, 2005). TheNESmutant Gag.L219A is a very
informative tool, permitting the examination of the intranuclear
activities of Gag, which are difficult to study using the wild-type
Gag protein because a small amount of Gag protein is present
in the nucleus. In this work, we focused on understanding the
characteristics of the nuclear Gag population and to identify
potential interacting partners within the nucleus.
With careful inspection, the wild-type Gag protein can
be detected within small nucleoplasmic foci (Figure 1B). The
Gag.L219A protein accumulated in similar nuclear puncta,
although the foci were larger and more numerous. The foci
formed by nuclear-restricted Gag proteins exhibited obstructed
diffusion with an average anomalous diffusion coefficient of
0.46, suggesting that Gag.L219A proteins are tethered to another
molecule within the nucleus. In an attempt to identify the
tethering partner, when we examined whether Gag.L219A was
associated with other subnuclear bodies that form intranuclear
foci. We found a high degree of co-localization with splicing
factors SC35 and SF2, although the co-localization was partial
(∼70%), suggesting that either Gag proteins move dynamically
between SF2/SC35 nuclear aggregates and other nucleoplasmic
sites, or a different molecule could be the Gag anchor.
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FIGURE 5 | The effect of Clk1 on Gag.L219A localization in QT6 cells. (A) Localization of Gag.L219A, Clk1, SC35, or SF2 in singly transfected QT6
cells. (B) Co-expression of Clk1 with Gag.L219A, SC35, or SF2 in QT6 cells. “Overlay” depicts a merge of the Clk1 and Gag.L219A or splicing factor
channels. The DAPI channel is also displayed. The percentage of Gag.L219A, SC35, or SF2 co-localizing with Clk1 is depicted in the corresponding
Gag.L219A, SC35, and SF2 channels with the standard error of the mean. (C) QT6 cells co-transfected with Gag.L219A, Clk1, and SC35 (top panel) or
SF2 (bottom panel). Merging the Gag.L219A and splicing factor channels results in the “Overlay” channel. The DAPI channel is also displayed. The
percentage of Gag.L219A co-localization with SC35 or SF2 in the presence of Clk1 overexpression is depicted in the corresponding Gag.L219A channel
with the standard error of the mean.
Finding that increased expression of SC35 induced an increase
in the number of Gag foci suggests that SC35 may facilitate the
formation of Gag.L219A nuclear puncta (Figure 6). Additional
experiments will need to be performed to examine whether
SC35 is required for the formation of Gag.L219A foci, whether
Gag interacts with SC35 and if so, whether the interaction is
direct or indirect. SF2 also co-localized with Gag foci (Figure 2),
and the degree of co-localization increased with co-expression
of the with SR protein kinase Clk1, which phosphorylates
the RS domain of splicing factors (Colwill et al., 1996).
These data suggest that Gag.L219A interacts more efficiently
with phosphorylated splicing factors, although alternatively, it
remains possible that Clk1 has pleiotropic effects on cellular
proteins that result in increased co-localization of Gag.L219A
with SF2 and SC35. Furthermore, we noted that SC35 and
SF2 appeared more diffuse in the nuclei of QT6 cells rather
than forming discrete puncta characteristic of splicing speckles
in HeLa cells (Figure 3). The localization of SR proteins is
dependent on phosphorylation of their RS domains by SRPKs,
including Clk1. Hyperphosphorylation of the RS domain of SF2
by Clk1 relocalizes SF2 from discrete nuclear speckles to the
nucleoplasm (Ngo et al., 2005), and other work has shown that
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FIGURE 6 | Quantification of Gag.L219A nuclear foci number with
co-expression of SC35, SF2, or PSP1. (A) Representative images of QT6
cells co-transfected with Gag.L219A and SC35, SF2, or PSP1.
(B) Quantification of the number of Gag.L219A nuclear foci in QT6 cells
expressing Gag.L219A alone or Gag.L219A co-transfected with SC35, SF2, or
PSP1. Mean and standard error of the mean are indicated for each transfection.
Nuclear foci in at least 16 QT6 nuclei were counted. *denotes p = 0.0003.
phosphorylation of the SR domain targets splicing factors to
nascent RNA transcripts (Misteli et al., 1998; Yeakley et al.,
1999). Therefore, the increased association of Gag.L219A with
hyperphosphorylated SR proteins implies that Gag.L219A may
preferentially associate with SR proteins that are primed for
splicing nascent transcripts at sites of transcription.
To explain the difference in appearance of nuclear foci formed
by SF2 and SC35 in avian cells compared to human cells, one
possibility is that avian SRPKs do not properly phosphorylate
human splicing factors (Gui et al., 1994; Colwill et al., 1996;
Nayler et al., 1997; Koizumi et al., 1999), causing them to
adopt a more diffuse localization. This idea is supported by the
observation that expression of Clk1 in QT6 cells was associated
with a more focal consolidation of Gag.L219A with SC35 and
SF2 (Figure 5C). However, we cannot rule out the possibility that
SC35 and SF2 require another host factor (protein or RNA) to
form splicing speckles in human cells (e.g., the long noncoding
RNA MALAT1) (Tripathi et al., 2010; Nakagawa et al., 2012),
which may not be present in avian cells. Whereas our data
suggests that Gag may co-localize with splicing factors SC35 and
SF2, whether these associations are at canonical speckles near
sites of transcription will require further examination.
Using a monoclonal antibody directed against the
phosphorylated RS domains of splicing factors to stain
for endogenous proteins, we observed that Gag.L219A
and endogenous phosphorylated splicing factors appeared
to be juxtaposed in HeLa cells (Figure 4C). Strikingly,
immunostaining with the anti-phospho RS domain antibody
was markedly reduced in HeLa cells that also co-expressed
Gag.L219A (Figure 4C). These findings combined with
the 3-dimensional reconstructions (shown in Figure 2 and
Supplemental Movies S1, S2) showing the close proximity of
Gag.L219A with SC35 and/or SF2 raises the possibility that Gag
may associate with splicing factors in splicing speckles, although
more experiments need to be performed to test this idea. The NC
domain of Gag.L219A is required for Gag to form intranuclear
foci and NC also mediates Gag-Gag and Gag-RNA interactions
(Kenney et al., 2008). Therefore, we must consider the idea that
the Gag nuclear tether could be a host RNA; thus, it is possible
that Gag.L219A interacts with SC35 and/or SF2 through an
RNA-mediated association.
Why might RSV Gag interact with splicing factors in
the nucleus? Considering our previous data linking nuclear
localization of Gag with efficient genomic RNA packaging
(Scheifele et al., 2002; Garbitt-Hirst et al., 2009), we hypothesize
that RSV Gag might enter the nucleus to package the viral
unspliced RNA genome shortly after it is synthesized. This
strategy would target Gag to the transcription site, which is where
the highest concentration of genome-length RNA is present in
the cell. Additionally, Gag would have access to viral RNA before
it could be spliced and could select the unspliced RNA as genome
rather than permitting its use as an mRNA. We propose that
RSV Gag could enter the nucleus, localizing at the periphery of
speckles near transcription factories (Sutherland and Bickmore,
2009) to gain access to nascent unspliced viral RNA to capture
it for packaging into virions. Other potential reasons for Gag to
localize near splicing factors include altering the splicing pattern
of host or viral RNAs or modifying nuclear export of viral or host
RNAs.
As a means to target the unspliced RSV RNA for packaging
by Gag, we propose that the NRS (negative regulator of
splicing), a cis-acting element in the gag coding region, may
play an important role. The RSV NRS regulates the balance
between spliced and unspliced RSV RNA (Arrigo and Beemon,
1988; McNally and Beemon, 1992) by binding to SFp30a/b (a
complex of SC35 and SF2) and U11/U12 snRNPs to form a
nonfunctional spliceosome that inhibits the upstream RSV 5′
splice site (Gontarek et al., 1993; McNally and McNally, 1996).
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Interestingly, the RSV psi packaging sequence is located on both
the spliced and unspliced viral RNA, yet the unspliced RNA
is preferentially packaged by Gag into new virions. Thus, we
speculate that the downstream pseudo-spliceosome assembled on
the NRS could “mark” the unspliced RNA as a potential genome.
Gag could interact with SC35 and SF2 bound to the NRS, scan
the RNA for the high affinity psi sequence, and ultimately select
an RNA containing both an NRS and psi as the genomic RNA.
Additionally, it is feasible that RSV Gag associates with splicing
factors to influence the global splicing program of the cell to
benefit virus replication.
Interestingly, numerous splicing factors were identified as
potential binding partners of the HIV-1 Gag protein using mass
spectrometry (Engeland et al., 2011, 2014), including PRPF3
and PRPF4 (components of the U4/U5/U6 tri-snRNP complex),
SFRS1 (SF2), SFRS2 (SC35), SFRS3 (SRp20), SRSF5 (SRp40),
SRSF6 (SRp55), SFSR7 (9G8), SFRS9 (SRp30c), SRPK1 (an SR
Protein Kinase). Additional investigation is required to address
whether HIV-1 Gag associates with these factors in cells and
whether splicing factors play a functional role in the replication
cycle beyond their influence on regulating alternative splicing of
retroviral RNAs.
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